Stay updated on Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The CheckMate 214 record is displayed with its study design, treatments, eligibility criteria, outcome measures, locations, and supporting documents.
    Difference
    100%
    Check dated 2026-11-11T01:37:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:50:15.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A sitewide banner announces a terminology change across NIH content, and the site revision advances from v3.7.1 to v3.7.2. The study page continues to display a 403 error rather than study details.
    Difference
    1%
    Check dated 2026-10-20T23:53:49.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The site footer’s revision number changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:12:50.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous visible content and indicating that the study page is currently restricted or unavailable.
    Difference
    0.5%
    Check dated 2026-09-30T00:08:26.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study content, with the site chrome and a Home button visible. This indicates the trial record is currently inaccessible due to access restrictions.
    Difference
    18%
    Check dated 2026-09-23T01:01:39.000Z thumbnail image

Stay in the know with updates to Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.